NCT00144534View on ClinicalTrials.gov

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MRA (Tocilizumab)

8mg/kg/4 weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT00144534 - Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP | Biotech Hunter | Biotech Hunter